We have fully integrated a critical mass of expertise in structural biology methods with medicinal chemistry and the experience to develop the full range of assays critical in discovery of drug candidates. That’s what makes our research team unique.

We have a strong, interdisciplinary team with expertise in:

  • Medicinal and Computational chemistry
  • Structural & Biophysical sciences
  • Cellular and Biochemical sciences
  • DMPK studies

This team has produced six development candidates in the past seven years, across a range of biological disciplines such as CNS, Pain and Oncology. These strengths have been endorsed through a continuing series of research collaborations with major pharmaceutical companies.

Our scientists are recognised as influential world leaders in fragment-based discovery, invited to speak at major conferences and with highly cited publications.